Follow Us On
Tablet
Files
Norgestimate and Ethinyl Estradiol, USP (Tri-Estarylla-TM)
Strength: 0.18mg/0.035mg, 0.215mg/0.035mg, and 0.25mg/0.035mg
Count: 3×28 Blister Card (84)
NDC
42291-590-84
Class
Rx
Brand Name
Tri-Lo-Estarylla
Imprint Code
SZ;T2
Color(s)
WHITE
Shape
ROUND
Score
no score
Case Count
NA
Inactive Ingredients
crospovidone, lactose anhydrous, magnesium stearate, and pregelatinized starch
Indications and Usage
1.1 Oral Contraceptive Tri-Estarylla™ (norgestimate and ethinyl estradiol tablets) is indicated for use by females of reproductive potential to prevent pregnancy 1.2 Acne Tri-Estarylla™ is indicated for the treatment of moderate acne vulgaris in females at least 15 years of age, who have no known contraindications to oral contraceptive therapy and have achieved menarche. Tri-Estarylla™ should be used for the treatment of acne only if the patient desires an oral contraceptive for birth control.
